China Pharma Holdings (CPHI) Current Taxes (2010 - 2026)
China Pharma Holdings (CPHI) posted Current Taxes of $370174.0 for Q1 2026, up 5.19% on a QoQ basis from $351904.0 in Q4 2025, and down 33.32% year-over-year from $555142.0 in Q1 2025.
China Pharma Holdings (CPHI) Current Taxes (2010 - 2026) Analysis & Trends
China Pharma Holdings' Current Taxes history runs 8 years deep, the most recent figure standing at $370174.0 for Q1 2026.
- Quarterly Current Taxes fell 33.32% year-over-year to $370174.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $370174.0 (down 33.32% YoY) and the FY2025 annual result came in at $351904.0, down 20.21% from the prior year.
- Current Taxes was $370174.0 for Q1 2026 at China Pharma Holdings, up from $351904.0 in the prior quarter.
- Across five years, Current Taxes topped out at $1.0 million in Q4 2023 and bottomed at $351904.0 in Q4 2025.
- A 4-year average of $572216.6 and a median of $498102.0 in 2024 frame the typical range for Current Taxes.
- Annual changes were most pronounced in 2024 — Current Taxes sank 57.06% — and 2025, when it surged 73.26%.
- China Pharma Holdings' Current Taxes stood at $1.0 million in 2023, then sank by 57.06% to $441062.0 in 2024, then decreased by 20.21% to $351904.0 in 2025, then climbed by 5.19% to $370174.0 in 2026.
- Business Quant data shows CPHI's Current Taxes at $370174.0 in Q1 2026, $351904.0 in Q4 2025, and $691677.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 355.15 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 211.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 624.14 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 640.78 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | China Pharma Holdings | 629,344.02 | 460,870.02 | 285,487.00 | 370,174.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 370,174.00 |
| Dec 31, 2025 | 351,904.00 |
| Sep 30, 2025 | 691,677.00 |
| Jun 30, 2025 | 741,376.00 |
| Mar 31, 2025 | 555,142.00 |
| Dec 31, 2024 | 441,062.00 |
| Sep 30, 2024 | 399,212.00 |
| Dec 31, 2023 | 1.03 Mn |
| Jun 30, 2013 | 690,781.00 |
| Mar 31, 2013 | 514,245.00 |
| Dec 31, 2012 | 2.43 Mn |
| Sep 30, 2012 | 3.02 Mn |
| Jun 30, 2012 | 3.27 Mn |
| Mar 31, 2012 | 3.54 Mn |
| Dec 31, 2011 | 3.08 Mn |
| Sep 30, 2011 | 3.30 Mn |
| Jun 30, 2011 | 3.36 Mn |
| Dec 31, 2010 | 2.39 Mn |